Bausch Health Companies (BHC) Operating Expenses (2009 - 2026)
Bausch Health Companies (BHC) posted Operating Expenses of $2.1 billion for Q2 2026, down 39.21% sequentially from $3.5 billion in Q1 2026, and up 1.25% YoY from $2.1 billion in Q2 2025.
Bausch Health Companies (BHC) Operating Expenses (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Operating Expenses for 18 years, with the latest figure at $2.1 billion in Q2 2026.
- Quarterly Operating Expenses rose 1.25% year-over-year to $2.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.0 billion (up 20.67% YoY) and the FY2025 annual result came in at $8.5 billion, up 4.63% from the prior year.
- Operating Expenses slipped to $2.1 billion in Q2 2026 per BHC's latest filing, from $3.5 billion in the prior quarter.
- Over five years, Operating Expenses peaked at $3.5 billion in Q1 2026 and troughed at $1.6 billion in Q1 2022.
- A 5-year average of $2.1 billion and a median of $2.0 billion in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2026: Operating Expenses dropped 27.36% in 2022, then soared 75.19% in 2026.
- Over 5 years, Operating Expenses stood at $2.4 billion in 2022, then declined by 15.77% to $2.0 billion in 2023, then fell by 2.2% to $2.0 billion in 2024, then grew by 16.04% to $2.3 billion in 2025, then slipped by 9.04% to $2.1 billion in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $2.1 billion, $3.5 billion, and $2.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 732.63 Mn | 2.10 Bn | 2.11 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.11 Bn |
| Mar 31, 2026 | 3.47 Bn |
| Dec 31, 2025 | 2.32 Bn |
| Sep 30, 2025 | 2.06 Bn |
| Jun 30, 2025 | 2.09 Bn |
| Mar 31, 2025 | 1.98 Bn |
| Dec 31, 2024 | 2.00 Bn |
| Sep 30, 2024 | 2.19 Bn |
| Jun 30, 2024 | 2.01 Bn |
| Mar 31, 2024 | 1.87 Bn |
| Dec 31, 2023 | 2.05 Bn |
| Sep 30, 2023 | 2.22 Bn |
| Jun 30, 2023 | 1.76 Bn |
| Mar 31, 2023 | 1.77 Bn |
| Dec 31, 2022 | 2.43 Bn |
| Sep 30, 2022 | 1.80 Bn |
| Jun 30, 2022 | 1.81 Bn |
| Mar 31, 2022 | 1.63 Bn |
| Dec 31, 2021 | 1.83 Bn |
| Sep 30, 2021 | 1.54 Bn |